|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
0 months to Feb 24, 2023
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from (used by) operating activities: | |||||
| Net income (loss) | |||||
| Less (income) loss from discontinued operations, net of taxes | |||||
| Adjustments to reconcile net income (loss) to net cash from (used by) operating activities: | |||||
| Amortization of fixed maturity securities discounts and premiums | |||||
| Net investment (gains) losses | |||||
| Changes in fair value of market risk benefits and associated hedges | |||||
| Charges assessed to policyholders | |||||
| Acquisition costs deferred | |||||
| Amortization of deferred acquisition costs and intangibles | |||||
| Deferred income taxes | |||||
| Derivative instruments, limited partnerships and other | |||||
| Long-term incentive compensation expense | |||||
| Change in certain assets and liabilities: | |||||
| Accrued investment income and other assets | |||||
| Insurance reserves | |||||
| Current tax liabilities | |||||
| Other liabilities, policy and contract claims and other policy-related balances | |||||
| Cash from (used by) operating activities—discontinued operations | |||||
| Net cash from operating activities | |||||
| Net cash from (used by) operating activities | |||||
| Cash flows from (used by) investing activities: | |||||
| Fixed maturity securities | |||||
| Commercial mortgage loans | |||||
| Limited partnerships and other invested assets | |||||
| Proceeds from sales of investments: | |||||
| Fixed maturity and equity securities | |||||
| Purchases and originations of investments: | |||||
| Fixed maturity and equity securities | |||||
| Commercial mortgage loans | |||||
| Limited partnerships and other invested assets | |||||
| Short-term investments, net | |||||
| Policy loans, net | |||||
| Proceeds from sale of business, net of cash transferred | |||||
| Proceeds from sale of property | |||||
| Other | |||||
| Cash used by investing activities—discontinued operations | |||||
| Net cash from (used by) investing activities | |||||
| Cash flows from (used by) financing activities: | |||||
| Deposits to universal life and investment contracts | |||||
| Withdrawals from universal life and investment contracts | |||||
| Proceeds from issuance of long-term debt | |||||
| Debt issuance costs | |||||
| Repayment and repurchase of long-term debt | |||||
| Proceeds from sale of subsidiary shares to noncontrolling interests | |||||
| Repurchase of subsidiary shares | |||||
| Treasury stock acquired in connection with share repurchases | |||||
| Dividends paid to noncontrolling interests | |||||
| Other, net | |||||
| Net cash from (used by) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Less cash, cash equivalents and restricted cash of discontinued operations at end of period | |||||
Loading...
